Gyvenimo aprašymas

Vardas ir pavardė Valentina Liakina
Išsilavinimas
Institucija Kvalifikacijos laipsnis, mokslo laipsnis, pedagoginis vardas Metai
Valstybinis Baltarusijos universitetas Biologija, aukštasis išsilavinimas 1981
Lietuvos mokslo taryba daktaras 1995
Darbo patirtis
Darbovietė Pareigos Laikotarpis
Biotechnologijos institutas Jaun. mokslo darbuotoja 1981-1994
VU Medicinos fakultetas vyriausioji mokslo darbuotoja 1994--
VU Gamtos fakultetas lektorė 2007-2009
VGTU Mechanikos fakultetas docentė 2012-2018
VilniusTech (VGTU), Fundamentinių mokslų fakultetas docentė 2018--
Svarbiausios publikacijos, monografijos, meno darbai, patentai
Mokslo kryptis Darbo pavadinimas ir aprašymas Metai
M001, N004 Liakina V, Speiciene D, Irnius A, Naraskeviciene J, Barakauskiene A, Semuchiniene T. Prevalence of cryoglobulinemia in patients with chronic HCV infection. // Med Sci Monit. 2002 Jan;8(1):CR31-6. 2002
M001, N004 Liakina V, Speiciené D, Irnius A, Semuchiniené T, Valantinas J. Association of the prevalence and grade of steatosis in patients with chronic hepatitis C with the host and viral factors. // Acta Gastroenterol Belg. 2007 Jul-Sep;70(3):260-6. 2007
M001 Speiciene D, Irnius A, Leuschner U, Liakina V, Semuchiniene T, Barakauskiene A. Primary biliary cirrhosis in Lithuania: diagnosis and clinical picture. // Med Sci Monit. 2007 Jul;13(7):CR299-306. 2007
M004 Liakina V, Speiciene D, Irnius A, Valantinas J.Changes in hepatitis C virus infection routes and genotype distribution in a Lithuanian cohort with chronic hepatitis C. // Med Sci Monit. 2009 Apr;15(4):PH17-23. 2009
M001, N004 Barakauskienė A, Speičienė D, Liakina V, Semuchinienė T, Valantinas J. Expression of cytokeratin 7 as a histological marker of cholestasis and stages of primary biliary cirrhosis. // Medicina (Kaunas). 2011;47(1):31-8. 2011
M004, N010 Liakina V, Valantinas J. Anti-HCV prevalence in the general population of Lithuania. // Med Sci Monit. 2012 Mar;18(3):PH28-35. 2012
M001, N004 Hirschfield GM, Xie G, Lu E, Sun Y, Juran BD, Chellappa V, Coltescu C, Mason AL, Milkiewicz P, Myers RP, Odin JA, Luketic VA, Bacon B, Bodenheimer H, Liakina V, Vincent C, Levy C, Pillai S, Lazaridis KN, Amos CI, Siminovitch KA. Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes. // Genes Immun. 2012 Jun;13(4):328-35. 2012
M001, N004 Juran BD, Hirschfield GM, Invernizzi P, Atkinson EJ, Li Y, Xie G, Kosoy R, Ransom M, Sun Y, Bianchi I, Schlicht EM, Lleo A, Coltescu C, Bernuzzi F, Podda M, Lammert C, Shigeta R, Chan LL, Balschun T, Marconi M, Cusi D, Heathcote EJ, Mason AL, Myers RP, Milkiewicz P, Odin JA, Luketic VA, Bacon BR, Bodenheimer HC Jr, Liakina V, Vincent C, Levy C, Franke A, Gregersen PK, Bossa F, Gershwin ME, deAndrade M, Amos CI; Italian PBC Genetics Study Group, Lazaridis KN, Seldin MF, Siminovitch KA. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. // Hum Mol Genet. 2012 Dec 1;21(23):5209-21. 2012
M001, N004 Visockiene Z, Brimas G, Abaliksta T, Siauliene L, Liakina V, Strupas K. Metabolic changes one year after laparoscopic adjustable gastric banding operation in morbidly obese subjects. // Wideochir Inne Tech Maloinwazyjne. 2013 Mar;8(1):13-21. 2013
M001, N004, N009 Savlan Ilona, Liakina Valentina, Valantinas Jonas, Value of computerized inhibitory control test and blood tests in minimal hepatic encephalopathy diagnosis // Acta medica Lituanica, Vilnius : Academia. ISSN 1392-0138. Vol. 20, no. 3 (2013) p. 109-116. 2013
M001 Savlan Ilona, Liakina Valentina, Valantinas Jonas, Concise review of current concepts on nomenclature and pathophysiology of hepatic encephalopathy // Medicina, Kaunas : Lithuanian University of Health Sciences. ISSN 1010-660X. Vol. 50, no. 2 (2014) p. 75-81. 2014
M001, N004 Cordell HJ, Han Y, Mells GF, Li Y, Hirschfield GM, Greene CS, Xie G, Juran BD, Zhu D, Qian DC, Floyd JA, Morley KI, Prati D, Lleo A, Cusi D; Canadian-US PBC Consortium; Italian PBC Genetics Study Group; UK-PBC Consortium, Gershwin ME, Anderson CA, Lazaridis KN, Invernizzi P, Seldin MF, Sandford RN, Amos CI, Siminovitch KA. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.//Nat Commun. 2015 Sep 22;6:8019. 2015
M000, M004 Alfaleh FZ, Nugrahini N, Matičič M, Tolmane I, Alzaabi M, Hajarizadeh B, Valantinas J, Kim DY, Hunyady B, Abaalkhail F, Abbas Z, Abdou A, Abourached A, Al Braiki F, Al Hosani F, Al Jaberi K, Al Khatry M, Al Mulla MA, Al Quraishi H, Al Rifai A, Al Serkal Y, Alam A, Alashgar HI, Alavian SM, Alawadhi S, Al-Dabal L, Aldins P, Alghamdi AS, Al-Hakeem R, Aljumah AA, Almessabi A, Alqutub AN, Alswat KA, Altraif I, Andrea N, Assiri AM, Babatin MA, Baqir A, Barakat MT, Bergmann OM, Bizri AR, Chaudhry A, Choi MS, Diab T, Djauzi S, El Hassan ES, El Khoury S, Estes C, Fakhry S, Farooqi JI, Fridjonsdottir H, Gani RA, Ghafoor Khan A, Gheorghe L, Goldis A, Gottfredsson M, Gregorcic S, Gunter J, Hamid S, Han KH, Hasan I, Hashim A, Horvath G, Husni R, Jafri W, Jeruma A, Jonasson JG, Karlsdottir B, Kim YS, Koutoubi Z, Lesmana LA, Liakina V, Lim YS, Löve A, Maimets M, Makara M, Malekzadeh R, Memon MS, Merat S, Mokhbat JE, Mourad FH, Muljono DH, Nawaz A, Olafsson S, Priohutomo S, Qureshi H, Rassam P, Razavi H, Razavi-Shearer D, Razavi-Shearer K, Rozentale B, Sadik M, Saeed K, Salamat A, Salupere R, Sanai FM, Sanityoso Sulaiman A, Sayegh RA, Schmelzer JD, Sharara AI, Sibley A, Siddiq M, Siddiqui AM, Sigmundsdottir G, Sigurdardottir B, Speiciene D, Sulaiman A, Sultan MA, Taha M, Tanaka J, Tarifi H, Tayyab G, Ud Din M, Umar M, Videčnik-Zorman J, Yaghi C, Yunihastuti E, Yusuf MA, Zuberi BF, Blach S. Strategies to manage hepatitis C virus infection disease burden - volume 3.// J Viral Hepat. 2015 Dec;22 Suppl 4:42-65. 2015
M000, M004 Sibley A, Han KH, Abourached A, Lesmana LA, Makara M, Jafri W, Salupere R, Assiri AM, Goldis A, Abaalkhail F, Abbas Z, Abdou A, Al Braiki F, Al Hosani F, Al Jaberi K, Al Khatry M, Al Mulla MA, Al Quraishi H, Al Rifai A, Al Serkal Y, Alam A, Alavian SM, Alashgar HI, Alawadhi S, Al-Dabal L, Aldins P, Alfaleh FZ, Alghamdi AS, Al-Hakeem R, Aljumah AA, Almessabi A, Alqutub AN, Alswat KA, Altraif I, Alzaabi M, Andrea N, Babatin MA, Baqir A, Barakat MT, Bergmann OM, Bizri AR, Blach S, Chaudhry A, Choi MS, Diab T, Djauzi S, El Hassan ES, El Khoury S, Estes C, Fakhry S, Farooqi JI, Fridjonsdottir H, Gani RA, Ghafoor Khan A, Gheorghe L, Gottfredsson M, Gregorcic S, Gunter J, Hajarizadeh B, Hamid S, Hasan I, Hashim A, Horvath G, Hunyady B, Husni R, Jeruma A, Jonasson JG, Karlsdottir B, Kim DY, Kim YS, Koutoubi Z, Liakina V, Lim YS, Löve A, Maimets M, Malekzadeh R, Matičič M, Memon MS, Merat S, Mokhbat JE, Mourad FH, Muljono DH, Nawaz A, Nugrahini N, Olafsson S, Priohutomo S, Qureshi H, Rassam P, Razavi H, Razavi-Shearer D, Razavi-Shearer K, Rozentale B, Sadik M, Saeed K, Salamat A, Sanai FM, Sanityoso Sulaiman A, Sayegh RA, Sharara AI, Siddiq M, Siddiqui AM, Sigmundsdottir G, Sigurdardottir B, Speiciene D, Sulaiman A, Sultan MA, Taha M, Tanaka J, Tarifi H, Tayyab G, Tolmane I, Ud Din M, Umar M, Valantinas J, Videčnik-Zorman J, Yaghi C, Yunihastuti E, Yusuf MA, Zuberi BF, Schmelzer JD. The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3.// J Viral Hepat. 2015 Dec;22 Suppl 4:21-41. 2015
M000, M004 Liakina V, Hamid S, Tanaka J, Olafsson S, Sharara AI, Alavian SM, Gheorghe L, El Hassan ES, Abaalkhail F, Abbas Z, Abdou A, Abourached A, Al Braiki F, Al Hosani F, Al Jaberi K, Al Khatry M, Al Mulla MA, Al Quraishi H, Al Rifai A, Al Serkal Y, Alam A, Alashgar HI, Alawadhi S, Al-Dabal L, Aldins P, Alfaleh FZ, Alghamdi AS, Al-Hakeem R, Aljumah AA, Almessabi A, Alqutub AN, Alswat KA, Altraif I, Alzaabi M, Andrea N, Assiri AM, Babatin MA, Baqir A, Barakat MT, Bergmann OM, Bizri AR, Blach S, Chaudhry A, Choi MS, Diab T, Djauzi S, El Khoury S, Estes C, Fakhry S, Farooqi JI, Fridjonsdottir H, Gani RA, Ghafoor Khan A, Goldis A, Gottfredsson M, Gregorcic S, Hajarizadeh B, Han KH, Hasan I, Hashim A, Horvath G, Hunyady B, Husni R, Jafri W, Jeruma A, Jonasson JG, Karlsdottir B, Kim DY, Kim YS, Koutoubi Z, Lesmana LA, Lim YS, Löve A, Maimets M, Makara M, Malekzadeh R, Matičič M, Memon MS, Merat S, Mokhbat JE, Mourad FH, Muljono DH, Nawaz A, Nugrahini N, Priohutomo S, Qureshi H, Rassam P, Razavi H, Razavi-Shearer D, Razavi-Shearer K, Rozentale B, Sadik M, Saeed K, Salamat A, Salupere R, Sanai FM, Sanityoso Sulaiman A, Sayegh RA, Schmelzer JD, Sibley A, Siddiq M, Siddiqui AM, Sigmundsdottir G, Sigurdardottir B, Speiciene D, Sulaiman A, Sultan MA, Taha M, Tarifi H, Tayyab G, Tolmane I, Ud Din M, Umar M, Valantinas J, Videčnik-Zorman J, Yaghi C, Yunihastuti E, Yusuf MA, Zuberi BF, Gunter J. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.// J Viral Hepat. 2015 Dec;22 Suppl 4:4-20. 2015
M004 Blach S, Zeuzem S, Manns M, Altraif I, Duberg AS, Muljono DH, Waked I, Alavian SM, Lee MH, Negro F, Abaalkhail F, Abdou A, Abdulla M, Rached AA, Aho I, Akarca U, Al Ghazzawi I, Al Kaabi S, Al Lawati F, Al Namaani K, Al Serkal Y, Al-Busafi SA, Al-Dabal L, Aleman S, Alghamdi AS, Aljumah AA, Al-Romaihi HE, Andersson MI, Arendt V, Arkkila P, Assiri AM, Baatarkhuu O, Bane A, Ben-Ari Z, Bergin C, Bessone F, Bihl F, Bizri AR, Blachier M, Blasco AJ, Mello CE, Bruggmann P, Brunton CR, Calinas F, Chan HL, Chaudhry A, Cheinquer H, Chen CJ, Chien RN, Choi MS, Christensen PB, Chuang WL, Chulanov V, Cisneros L, Clausen MR, Cramp ME, Craxi A, Croes EA, Dalgard O, Daruich JR, de Ledinghen V, Dore GJ, El-Sayed MH, Ergör G, Esmat G, Estes C, Falconer K, Farag E, Ferraz ML, Ferreira PR, Flisiak R, Frankova S, Gamkrelidze I, Gane E, García-Samaniego J, Khan AG, Gountas I, Goldis A, Gottfredsson M, Grebely J, Gschwantler M, Pessôa MG, Gunter J, Hajarizadeh B, Hajelssedig O, Hamid S, Hamoudi W, Hatzakis A, Himatt SM, Hofer H, Hrstic I, Hui YT, Hunyady B, Idilman R, Jafri W, Jahis R, Janjua NZ, Jarčuška P, Jeruma A, Jonasson JG, Kamel Y, Kao JH, Kaymakoglu S, Kershenobich D, Khamis J, Kim YS, Kondili L, Koutoubi Z, Krajden M, Krarup H, Lai MS, Laleman W, Lao WC, Lavanchy D, Lázaro P, Leleu H, Lesi O, Lesmana LA, Li M, Liakina V, Lim YS, Luksic B, Mahomed A, Maimets M, Makara M, Malu AO, Marinho RT, Marotta P, Mauss S, Memon MS, Correa MC, Mendez-Sanchez N, Merat S, Metwally AM, Mohamed R, Moreno C, Mourad FH, Müllhaupt B, Murphy K, Nde H, Njouom R, Nonkovic D, Norris S, Obekpa S, Oguche S, Olafsson S, Oltman M, Omede O, Omuemu C, Opare-Sem O, Øvrehus AL, Owusu-Ofori S, Oyunsuren TS, Papatheodoridis G, Pasini K, Peltekian KM, Phillips RO, Pimenov N, Poustchi H, Prabdial-Sing N, Qureshi H, Ramji A, Razavi-Shearer D, Razavi-Shearer K, Redae B, Reesink HW, Ridruejo E, Robbins S, Roberts LR, Roberts SK, Rosenberg WM, Roudot-Thoraval F, Ryder SD, Safadi R, Sagalova O, Salupere R, Sanai FM, Avila JF, Saraswat V, Sarmento-Castro R, Sarrazin C, Schmelzer JD, Schréter I, Seguin-Devaux C, Shah SR, Sharara AI, Sharma M, Shevaldin A, Shiha GE, Sievert W, Sonderup M, Souliotis K, Speiciene D, Sperl J, Stärkel P, Stauber RE, Stedman C, Struck D, Su TH, Sypsa V, Tan SS, Tanaka J, Thompson AJ, Tolmane I, Tomasiewicz K, Valantinas J, Van Damme P, van der Meer AJ, van Thiel I, Van Vlierberghe H, Vince A, Vogel W, Wedemeyer H, Weis N, Wong VW, Yaghi C, Yosry A, Yuen MF, Yunihastuti E, Yusuf A, Zuckerman E, Razavi H. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. // Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176. doi: 10.1016/S2468-1253(16)30181-9. Epub 2016 Dec 16. 2017
M004, N009, N004 Razavi H, Robbins S, Zeuzem S, Negro F, Buti M, Duberg AS, Roudot-Thoraval F, Craxi A, Manns M, Marinho RT, Hunyady B, Colombo M, Aleman S, Antonov K, Arkkila P, Athanasakis K, Blach S, Blachier M, Blasco AJ, Calinas F, Calleja JL, Christensen PB, Cramp ME, Croes E, de Knegt RJ, de Ledinghen V, Delile JM, Estes C, Falconer K, Färkkilä M, Flisiak R, Frankova S, Gamkrelidze I, García-Samaniego J, Genov J, Gerstoft J, Gheorghe L, Goldis A, Gountas I, Gregorčič S, Gschwantler M, Gunter J, Halota W, Harcouet L, Hézode C, Hoffmann P, Horvath G, Hrstic I, Jarčuška P, Jelev D, Jeruma A, Kåberg M, Kieran J, Kondili LA, Kotzev I, Krarup H, Kristian P, Lagging M, Laleman W, Lázaro P, Liakina V, Lukšić B, Maimets M, Makara M, Mateva L, Maticic M, Mennini FS, Mitova R, Moreno C, Mossong J, Murphy K, Nde H, Nemecek V, Nonkovic D, Norris S, Oltman M, Øvrehus AL, Papatheodoridis G, Pasini K, Razavi-Shearer D, Razavi-Shearer K, Reesink HW, Reic T, Rozentale B, Ryder SD, Salupere R, Sarmento-Castro R, Sarrazin C, Schmelzer JD, Schréter I, Seguin-Devaux C, Simojoki K, Simonova M, Smit PJ, Souliotis K, Speiciene D, Sperl J, Stärkel P, Struck D, Sypsa V, Thornton L, Tolmane I, Tomasiewicz K, Valantinas J, Van Damme P, van de Vijver D, van der Meer AJ, van Santen D, Van Vlierberghe H, Vandijck D, Vella S, Videčnik-Zorman J, Vogel W, Weis N, Hatzakis A. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.//Lancet Gastroenterol Hepatol. 2017 May;2(5):325-336. doi: 10.1016/S2468-1253(17)30045-6. Epub 2017 Mar 15. 2017
N004, N010 Hinkula J, Petkov S, Ljungberg K, Hallengärd D, Bråve A, Isaguliants M, Falkeborn T, Sharma S, Liakina V, Robb M, Eller M, Moss B, Biberfeld G, Sandström E, Nilsson C, Markland K, Blomberg P, Wahren B. HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV. // Heliyon. 2017 Jun 29;3(6):e00339. doi: 10.1016/j.heliyon.2017.e00339. eCollection 2017 Jun. [IF=0.355] 2017
N004, M001 Buivydiene A, Liakina V, Valantinas J, Norkuniene J, Mockiene E, Jokubauskiene S, Smaliukiene R, Jancoriene L, Kovalevska L, Kashuba E. Expression Levels of the Uridine-Cytidine Kinase Like-1 Protein as a Novel Prognostic Factor for the Hepatitis C Virus-associated Hepatocellular Carcinomas. //Acta Naturae 2017;Jul-Sep;9(3):108-114. PMID: 29104783. [IF=0.841] 2017
N004, N010 Joachim A, Munseri PJ, Nilsson C, Bakari M, Aboud S, Lyamuya EF, Tecleab T, Liakina V, Scarlatti G, Robb M, Earl P, Moss B, Wahren B, Mhalu F, Ferarri G, Sandström E, Biberfeld G. Three-year durability of immune responses induced by HIV-DNA and HIV-modified vaccinia virus Ankara and effect of a late HIV-MVA boost in Tanzanian volunteers. // AIDS Res Hum Retroviruses. 2017. Aug;33(8):880-888. doi: 10.1089/AID.2016.0251. Epub 2017 Jan 27. [IF=1.935] 2017
M004 Razavi-Shearer D, Gamkrelidze I, Nguyen MH, Chen D-Sh, Van Damme P, Abbas Z, Abdulla M, Abou Rached A, Adda D, Aho I, Akarca U, Al Ali FH, Lawati FAI, Naamani KAI, Alashgar HI, Alavian SM, Alawadhi S, Albillos A, Al-Busafi SA, Aleman S, Alfaleh FZ, Aljumah AA, Anand AC, Anh NT, Arends JE, Arkkila P, Athanasakis K, Bane A, Ben-Ari Z, Berg T, Bizri AR, Blach S, Brandão Mello CE, Brandon SM, Bright B, Bruggmann P, Brunetto M, Buti M, Chan HLY, Chaudhry A, Chien R-N, Choi MS, Christensen PB, Chuang W-L, Chulanov V, Clausen MR, Colombo M, Cornberg M, Cowie B, Craxi A, Croes EA, Cuellar DA, Cunningham Ch, Desalegn H, Drazilova S, Duberg A-S, Egeonu SS, El-Sayed MH, Estes Ch, Falconer K, Ferraz MLG, Ferreira PR, Flisiak R, Frankova S, Gaeta GB, García-Samaniego J, Genov J, Gerstoft J, Goldis A, Gountas I, Gray R, Pessôa MG, Hajarizadeh B, Hatzakis A, Hézode Ch, Himatt SM, Hoepelman A, Hrstic I, Hui Y-TT, Husa P, Jahis R, Janjua NZ, Jarčuška P, Jaroszewicz J, Kaymakoglu S, Kershenobich D, Kondili LA, Konysbekova A, Krajden M, Kristian P, Laleman W, Lao WCL, Layden J, Lazarus JV, Lee M-H, Liakina V, Lim Y-SS, Loo ChK, Lukšić B, Malekzadeh R, Malu AO, Mamatkulov A, Manns M, Marinho RT, Maticic M, Mauss S, Memon MS, Correa MCM, Mendez-Sanchez N, Merat S, Metwally AM, Mohamed R, Mokhbat JE, Moreno Ch, Mossong J, Mourad FH, Müllhaupt B, Kimberly Murphy K, Musabaev E, Nawaz A, Nde HM, Negro F, Nersesov A, Nguyen VTT, Njouom R, Ntagirabiri R, Nurmatov Z, Obekpa S, Ocama P, Oguche S, Omede O, Omuemu C, Opare-Sem O, Opio ChK, Örmeci N, Papatheodoridis G, Pasini K, Pimenov N, Poustchi H, Quang TD, Qureshi H, Ramji A, Razavi-Shearer K, Redae B, Reesink HW, Rios CY, Rjaskova G, Robbins S, Roberts LR, Roberts SK, Ryder SD, Safadi R, Sagalova O, Salupere R, Sanai FM, Sanchez-Avila JF, Saraswat V, Sarrazin Ch, Schmelzer JD, Schréter I, Scott J, Seguin-Devaux C, Shah SR, Sharara AI, Sharma M, Shiha GE, Shin T, Sievert W, Sperl J, Stärkel P, Stedman C, Sypsa V, Tacke F, Tan SS, Tanaka J, Tomasiewicz K, Urbanek P, van der Meer AJ, Van Vlierberghe H, Vella S, Vince A, Waheed Y, Waked I, Walsh N, Weis N, Wong VW, Woodring J, Yaghi C, Yang H-I, Yang C-L, Yesmembetov K, Yosry A, Yuen M-F, Yusuf MAM, Zeuzem S, Razavi H. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.//Lancet Gastroenterol Hepatol 2018; Jun;3(6):383-403. Published online March 26, 2018 http://dx.doi.org/10.1016/S2468-1253(18)30056-6 . .[IF=13,39] 2018
M004 Razavi-Shearer D, Gamkrelidze I, Nguyen MH, Chen D-Sh, Van Damme P, Abbas Z, Abdulla M, Abou Rached A, Adda D, Aho I, Akarca U, Al Ali FH, Lawati FAI, Naamani KAI, Alashgar HI, Alavian SM, Alawadhi S, Albillos A, Al-Busafi SA, Aleman S, Alfaleh FZ, Aljumah AA, Anand AC, Anh NT, Arends JE, Arkkila P, Athanasakis K, Bane A, Ben-Ari Z, Berg T, Bizri AR, Blach S, Brandão Mello CE, Brandon SM, Bright B, Bruggmann P, Brunetto M, Buti M, Chan HLY, Chaudhry A, Chien R-N, Choi MS, Christensen PB, Chuang W-L, Chulanov V, Clausen MR, Colombo M, Cornberg M, Cowie B, Craxi A, Croes EA, Cuellar DA, Cunningham Ch, Desalegn H, Drazilova S, Duberg A-S, Egeonu SS, El-Sayed MH, Estes Ch, Falconer K, Ferraz MLG, Ferreira PR, Flisiak R, Frankova S, Gaeta GB, García-Samaniego J, Genov J, Gerstoft J, Goldis A, Gountas I, Gray R, Pessôa MG, Hajarizadeh B, Hatzakis A, Hézode Ch, Himatt SM, Hoepelman A, Hrstic I, Hui Y-TT, Husa P, Jahis R, Janjua NZ, Jarčuška P, Jaroszewicz J, Kaymakoglu S, Kershenobich D, Kondili LA, Konysbekova A, Krajden M, Kristian P, Laleman W, Lao WCL, Layden J, Lazarus JV, Lee M-H, Liakina V, Lim Y-SS, Loo ChK, Lukšić B, Malekzadeh R, Malu AO, Mamatkulov A, Manns M, Marinho RT, Maticic M, Mauss S, Memon MS, Correa MCM, Mendez-Sanchez N, Merat S, Metwally AM, Mohamed R, Mokhbat JE, Moreno Ch, Mossong J, Mourad FH, Müllhaupt B, Kimberly Murphy K, Musabaev E, Nawaz A, Nde HM, Negro F, Nersesov A, Nguyen VTT, Njouom R, Ntagirabiri R, Nurmatov Z, Obekpa S, Ocama P, Oguche S, Omede O, Omuemu C, Opare-Sem O, Opio ChK, Örmeci N, Papatheodoridis G, Pasini K, Pimenov N, Poustchi H, Quang TD, Qureshi H, Ramji A, Razavi-Shearer K, Redae B, Reesink HW, Rios CY, Rjaskova G, Robbins S, Roberts LR, Roberts SK, Ryder SD, Safadi R, Sagalova O, Salupere R, Sanai FM, Sanchez-Avila JF, Saraswat V, Sarrazin Ch, Schmelzer JD, Schréter I, Scott J, Seguin-Devaux C, Shah SR, Sharara AI, Sharma M, Shiha GE, Shin T, Sievert W, Sperl J, Stärkel P, Stedman C, Sypsa V, Tacke F, Tan SS, Tanaka J, Tomasiewicz K, Urbanek P, van der Meer AJ, Van Vlierberghe H, Vella S, Vince A, Waheed Y, Waked I, Walsh N, Weis N, Wong VW, Woodring J, Yaghi C, Yang H-I, Yang C-L, Yesmembetov K, Yosry A, Yuen M-F, Yusuf MAM, Zeuzem S, Razavi H. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.//Lancet Gastroenterol Hepatol 2018; Jun;3(6):383-403. Published online March 26, 2018 http://dx.doi.org/10.1016/S2468-1253(18)30056-6 . .[IF=13,39] 2018
N004, M001 Buivydiene A, Liakina V, Kashuba E, Norkuniene J, Jokubauskiene S, Gineikiene E, Valantinas J. Impact of the Uridine⁻Cytidine Kinase Like-1 Protein and IL28B rs12979860 and rs8099917 SNPs on the Development of Hepatocellular Carcinoma in Cirrhotic Chronic Hepatitis C Patients-A Pilot Study. Medicina (Kaunas). 2018 Sep 27;54(5):67. DOI: 10.3390/medicina54050067. .[IF=1,467] 2018
M001 Stundiene I, Sarnelyte J, Norkute A, Aidietiene S, Liakina V, Masalaite L, Valantinas J. Liver cirrhosis and left ventricle diastolic dysfunction: Systematic review. World J Gastroenterol 2019; 25(32): 4779-4795. Published online Aug 28, 2019 Aug 28; 25(32):4779-4795. Doi:10.3748/wjg.v25.i32.4779 .[IF=3,665] 2019
M001 Stundiene I, Maksimaityte V, Liakina V, Valantinas J. Mucosa-associated lymphoid tissue simulating Crohn‘s disease: A case report. World J Clin Cases 2020; 8(8):1454-1462. Published online Apr 26, 2020. Doi: 10.12998/wjcc.v8.i8.1454. .[IF=1,013] 2020
M001 Strainienė S, Sarlauskas L, Savlan I, Liakina V, Stundienė I, Valantinas J. Multi-organ IgG4-related disease continues to mislead clinicians: A case report and literature review. World J Clin Cases. 2020 Aug 6; 8(15): 3267-3279. DOI: 10.12998/wjcc.v8.i15.3267.[IF=1,013] 2020
M004 Polaris Observatory Collaborators. The case for simplifying and using absolute targets for viral hepatitis elimination goals. J Viral Hepat. 2021 Jan;28(1):12-19. doi: 10.1111/jvh.13412. Epub 2020 Nov 4. PMID: 32979881. [IF=3.561] 2021
M000 Strainiene S, Sedleckaite K, Jarasunas J, Savlan I, Stanaitis J, Stundiene I, Strainys T, Liakina V, Valantinas J. Complicated course of biliary inflammatory myofibroblastic tumor mimicking hilar cholangiocarcinoma: A case report and literature review. World J Clin Cases 2021;9(21):6155-6169. Published online Jul 26, doi: 10.12998/wjcc.v9.i21.6155 [IF=1.337] 2021
M001 Strainienė S, Jauniškis K, Savlan I, Pamedys J, Stundienė I, Liakina V, Valantinas J. Paraneoplastic Phenomena of Disseminated Intravascular Coagulopathy in Hepatic Angiosarcoma – Rare, Challenging and Fatal. Case Report and Literature Review. Acta Medica Lithuanica 2021;28(2):199-212. Online ahead of print DOI:https://doi.org/10.15388/Amed.2021.28.2.1 2021
M001 Strainiene S, Peciulyte M, Strainys T, Stundiene I, Savlan I, Liakina V, Valantinas J. Management of Flood syndrome: What can we do better? World J Gastroenterol 2021;27(32):5297-5305. Published online Aug 28, doi: 10.3748/wjg.v27.i32.5297 [IF=5.742] 2021
M001, N004 Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Polaris Observatory HCV Collaborators //Lancet Gastroenterol Hepatol . 2022 May;7(5):396-415. doi: 10.1016/S2468-1253(21)00472-6. Epub 2022 Feb 16. 2022
M001, N004 Liakina V, Strainiene S, Stundiene I, Maksimaityte V, Kazenaite E. Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis.// World J Hepatol. 2022 Jul 27;14(7):1277-1290. doi: 10.4254/wjh.v14.i7.1277. PMID: 36158907 2022
M001, N004 Liakina V, Stundiene I, Milaknyte G, Bytautiene R, Reivytyte R, Puronaite R, Urbanoviciute G, Kazenaite E. Effects of COVID-19 on the liver: The experience of a single center.// World J Gastroenterol. 2022 Oct 21;28(39):5735-5749. doi: 10.3748/wjg.v28.i39.5735. PMID: 36338891 2022
Svarbiausi pranešimai konferencijose
Data Konferencijos ir pranešimo pavadinimas
2009-09-24 Liakina V, Speičienė D, Barakauskienė A, Valantinas J. Presentation of steatosis in primary biliary cirrhosis and chronic hepatitis c: similarities and differences. // NAFLD/NASH and related metabolic disease : EASL special conference, Bologna, September 24-26, 2009 : programme and abstracts. Bologna, 2009. p. 92.
2009-09-24 Liakina V, Speičienė D, Barakauskienė A, Valantinas J. Presentation of steatosis in primary biliary cirrhosis and chronic hepatitis c: similarities and differences. // NAFLD/NASH and related metabolic disease : EASL special conference, Bologna, September 24-26, 2009 : programme and abstracts. Bologna, 2009. p. 92.
2009-12-09 Jasaitytė R, Grabauskienė V, Jasevičiūtė A, Irnius A, Liakina V, Brašiškienė S, Valantinas J. The role of standard echocardiography and myocardial tissue Doppler imaging in the screening of latent cirrhotic cardiomyopathy // Abstracts of EUROECHO 2009, the 13th annual meeting of the European association of echocardiography, 9-12 December 2009, Madrid, Spain. European Journal of Echocardiography. 2009, vol. 10, suppl.2 : p ii179.
2010-06-08 Liakina V. Centre of Hepatology, Gastroenterology and Dietetics (Vilnius University, Lithuania) Open Information Day – FP7 Health Research: Brokerage Event for „HEALTH“ in the 7th Framework Programme (FP7). June 8th 2010, Centre Borschette Brussels (Belgium). Žodinis pranešimas.
2011-11-04 Hirschfield GM, Xie G, Lu E, Juran BD, Mason AL,Milkiewicz P, Myers RP, Luketic VA, Bacon BR, Bodenheimer HC, Odin JA, Liakina V, Vincent C, Levy C, Coltesku C, Lazaridis K, Amos C, Siminovitch K. Indentification of SOCS1 as a risk locus for patients with primary biliary cirrhosis. 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, CA, Nov 04-08, 2011// Hepatology 2011;54(Suppl.1):429A-430A. Abstract and oral presentation.
2012-04-03 Liakina V. Routes of nosocomial transmission of HCV. The 9th Annual Conference on Hepatitis C. New Visby Network. 2012-04-03, St.Peterburgas, Rusija
2012-04-18 Hirschfield GM, Juran BD, Invernizzi P, Atkinson EJ, Li Y, Xie G, Kosoy R, Ransom M, Sun Y, Bianchi I, Schlicht EM, Lleo A, Coltescu C, Bernuzzi F, Lammert C, Shigetta R, Chan LL, Balschun T, Marconi M, Cusi D, Mason AL, Myers RP, Milkiewicz P, Odin JA, Luketic V A, Bacon B, Bodenheimer H, Liakina V, Vincent C, Levy C, Franke A, Gregerson PK, Annese V, Gershwin ME, de Andrade M, Amos CI, Lazaridis KN, Seldin MF, Siminovitch KA. Discovery of a direct association between primary biliary cirrhosis and low bone mass: indentification of TNFSF11/RANKL as a risk locus for patient with PBC.// 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Barcelona, SPAIN, APR 18-22, 2012. Journal of Hepatology 2012;56(Suppl. 2):S550-S551. Meeting Abstract: 1400
2013-02-10 Savlan I, Liakina V, Valantinas J. Chronic hepatitis C impairs psychomotor functions of the infected subjects. The 10th Annual Conference of New Visby Network on Hepatitis C. February 10-13, 2013 Riga (Latvia) Oral presentation
2013-02-10 Liakina V, Wahren B. Analysis of anti-HIV serological responses after HIV vaccination. The 10th Annual Conference of New Visby Network on Hepatitis C. February 10-13, 2013 Riga (Latvia) Oral presentation
2013-04-24 Savlan I, Valantinas J, Audronytė E, Aksionova D, Liakina V. Minimal neuropsychomotor disorders in patients with chronic hepatitis C.// EASL2013 International Liver Congress TM 2013 (ILC),Amsterdam (Netherlands), April 24-28, 2013. Journal of Hepatology 2013;58 Supplement 1:S201-S202. Poster presentation
2013-11-14 J. Valantinas, V. Liakina Anti-HCV antikūnų paplitimas ir asimptominių lėtinių C hepatitų dažnis Lietuvos populiacijoje. „Užkrečiamųjų ligų aktualijos Lietuvoje - 2013 m.“ Nacionalinė užkrečiamųjų ligų konferencija, 2013 m. lapkričio 14 d, Vilnius. Žodinis pranešimas
2014-04-24 Liakina V, Buivydienė A, Brašiškienė S, Valantinas J. Asymptomatic hepatitis C prevalence in anti-HCV positive subjects (population based study).// 11th Annual Conference of the Baltic Network Against Life-threatening Viral Infections. April 24-27, 2014 Vilnius, Lithuania. Oral presentation.
2014-10-02 Liakina V, Valantinas J. Ūmais hepatito B paplitimas tarp aukštųjų mokyklų studentų.//2-oji Nacionalinė užkrečiamųjų ligų konferencija. Spalio 2,2014 Vilnius. Stendinis pranešimas
2015-11-19 Liakina V. „Changes in hepatitis C virus infection routes and genotype distribution in a Lithuanian cohort with chronic hepatitis C“.//Viral Hepatitis prevention board meeting „Prevention and control of viral hepatitis in the Baltic states: lessons learnt and the way forward“. 19-20 November 2015. Riga (Latvia) Kviestinis žodinis pranešimas.
2016-06-13 Buivydiene A, Buivydiene A, Jokubauskiene S, Norkuniene J, Liakina V, Jancioriene L, Valantinas J, Kashuba E. Hepatitis C virus positive hepatocellular carcinoma recurrence free survival and the UCKL-1 and S18-2 expression. International Scientific Conference „Integrated Clinical and Pathogenetic Approaches in Diagnosis and Therapy of Cancer“ Kyiv, Ukraine, June 13-15 2016.
2016-06-14 Buivydiene A, Jokubauskiene S, Liakina V, Kashuba E, Valantinas V. The expression of protein with uridine kinase activity UCKL-1 and mitochondrial ribosomal protein S18-2 in hepatitis C related liver cirrhosis and hepatocellular carcinoma. The 3rd International Conference “Evolutionary medicine: pre-existing mechanisms and patterns of current health issues”. 14-06-2016 – 19-06-2016, Vilnius, Lithuania
2016-07-26 Buivydiene A, Liakina V, Valantinas J, Smaliukiene R, Jokubauskiene S, Besusparis J, Kashuba E. The UCKL-1, a protein with uridine kinase activity, is a putative prognostic marker for hepatocellular carcinoma progression in patients with HCV-related cirrhosis. Vilnius International Summit on Communicable Diseases 26 June - 1 July 2016, Vilnius
2016-10-10 Buivydiene A, Jokubauskaite S, Norkuniene J, Liakina V, Kashuba E, Valantinas J. The association of genetic variation near interleukin 28B and UCKL-1 protein expression in liver tissue of patients with hepatitis C induced hepatocellular carcinoma World Congress on Hepatitis and Liver Diseases, October 10-12 2016, Dubai, JAE
Užsienio kalba
A1/2: pradedantis vartotojas; B1/2: pažengęs vartotojas; C1/2: įgudęs vartotojas;
Kalbėjimas Supratimas Rašymas
anglų B2 C1 C1
baltarusių B2 C2 B1
lenkų B2 C1 A2
rusų C2 C2 C1
švedų A1 A2 A2
ukrainiečių A2 B2 A1
vokiečių A1 A1 A1
Dėstomi studijų dalykai
Studijų pakopa Studijų dalykas
Antrosios pakopos Magistro baigiamasis darbas
Pirmosios pakopos Molekulinė ir ląstelės biologija
Pirmosios pakopos Bakalauro baigiamasis darbas 2
Pirmosios pakopos Bakalauro baigiamasis darbas 3
Kvalifikacijos tobulinimas (stažuotės, ilgesnės nei 2 savaitės; mokymai, seminarai, ne trumpesni nei 8 akad. val.; išvykos pagal mainų programas)
Institucija Šalis Tematika Laikotarpis
Karolinska universitetas Mikrobiologijos, vėžio ir ląstelės biologijos skyrius (MTC) Stokholmas, Švedija Anti-HIV serologinio atsako anlizė po HIV vakcinacijos 2012-2013
Karolinska universitetas Švedija Imuninio atsako į anti-ŽIV DNR vakciną tyrimas. 2014-2014
VGTU Studijų direkcija Vilnius, Lietuva Andragogikos pagrindai 2015-2015
Vilniaus universitetas Lietuva Assessment of learning outcomes in medicine. 2017-2017
Vilniaus universitetas Lietuva Constructive alignment between learning outcomes, pedagogy, and assessment in higher education. 2019-2019
Vilniaus universitetas Lietuva Sudentų darbas grupėse. 2019-2019
Vilniaus universitetas Lietuva Aktyvaus mokymosi metodų mokymai-dirbtuvės. 2019-2019
Dalyvavimas projektuose
Laikotarpis Projekto aprašymas
2006-0207 „Naujų serologinių antivirusinio gydymo prognozės rodiklių paieška sergantiesiems lėtiniu virusiniu C hepatitu”
2008-2020 "Šeimų tyrimas dėl pirminės bilijinės cirozės"
2010-2013 „Anti-HCV paplitimas bendroje Lietuvos populiacijoje“
2015-2015 “The disease burden of hepatitis C virus (HCV) infection and develop strategies that can manage the burden”, Center for Disease Analysis (Louisville, CO, USA). Koordinatorė Lietuvoje
2015-2018 Tarptautinis projektas „Family Studies in Primary Biliary Cirrhosis” („Šeimų tyrimas dėl pirminės biliarinės kepenų cirozės“). Koordinavimas Lietuvoje.
2016-2016 „HBV infection burden“, Center for Disease Analysis (Louisville, CO, USA). Koordinavimas Lietuvoje.
2016-2018 Lietuvos-Ukrainos dvišalės programos projektas „Sąveikaujančių su Epštein-Baro viruso branduoliniais antigenais baltymų XAP-2, UCKL-1 ir MRPS 18-2 ekspresijos palyginimas normaliajame kepenų audinyje ir hepatoceliulinės karcinomos žydiniuose“. Projekto vadovė.
Narystė tarptautinėse organizacijose, komitetuose, ekspertinė veikla, dalyvavimas redkolegijose
Laikotarpis Pavadinimas
1995-- Lietuvos imunologų draugija
1995-- Lietuvos gastroenterologų draugija
2001-- Europos hepatologų draugija
Kita veikla
Straipsnių recenzavimas žurnalams Medical Science Monitor, Therapeutic Advances in Gastroenterology, Journal of Clinical Medicine, Word Journal of Clinical Cases, World Journal of Gastroenterology, Biomedicines, Cancers, World Journal of Oncology, Nutrients, Pathogenes, International Journal of Molecular Science, Genes.